SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040670
Filing Date
2023-08-09
Accepted
2023-08-09 16:34:21
Documents
97
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20230630.htm   iXBRL 10-Q 2994991
2 EX-31.1 orgo-ex31_1.htm EX-31.1 19538
3 EX-31.2 orgo-ex31_2.htm EX-31.2 20033
4 EX-32.1 orgo-ex32_1.htm EX-32.1 21691
  Complete submission text file 0000950170-23-040670.txt   11757604

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgo-20230630.xsd EX-101.SCH 71894
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgo-20230630_lab.xml EX-101.LAB 524072
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT orgo-20230630_def.xml EX-101.DEF 277843
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgo-20230630_pre.xml EX-101.PRE 438083
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT orgo-20230630_cal.xml EX-101.CAL 64433
91 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20230630_htm.xml XML 2464903
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 231155747
SIC: 2834 Pharmaceutical Preparations